Details of the Drug

General Information of Drug (ID: DMJ7QP8)

Drug Name
AN-019
Synonyms NRC-19; NRC-24; NRC-AN-015; NRC-AN-019; Bcr-Abl inhibitors (CML), Natco
Indication
Disease Entry ICD 11 Status REF
Chronic myelogenous leukaemia 2A20.0 Phase 2 [1]
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
11562629
TTD ID
D04BXX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fusion protein Bcr-Abl (Bcr-Abl) TTS7G69 BCR_HUMAN-ABL1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031662)
2 Design, synthesis and preclinical evaluation of NRC-AN-019. Int J Oncol. 2013 Jan;42(1):168-78.